Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0TB4A
|
||||
Former ID |
DNC013275
|
||||
Drug Name |
Dmt-Pro-Emp-Phe-NH2
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528832] | ||
Structure |
Download2D MOL |
||||
Formula |
C37H47N5O5
|
||||
Canonical SMILES |
CCC1=CC=CC(=C1CC(C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C3CC<br />CN3C(=O)C(CC4=C(C=C(C=C4C)O)C)N)C
|
||||
InChI |
1S/C37H47N5O5/c1-5-26-14-9-11-22(2)29(26)21-32(35(45)40-31(34(39)44)19-25-12-7-6-8-13-25)41-36(46)33-15-10-16-42(33)37(47)30(38)20-28-23(3)17-27(43)18-24(28)4/h6-9,11-14,17-18,30-33,43H,5,10,15-16,19-21,38H2,1-4H3,(H2,39,44)(H,40,45)(H,41,46)/t30-,31-,32-,33-/m0/s1
|
||||
InChIKey |
FZEQHIVEBCRYJC-YRCZKMHPSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Kappa-type opioid receptor | Target Info | Inhibitor | [528832] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528832] | ||
Mu-type opioid receptor | Target Info | Inhibitor | [528832] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Opioid prodynorphin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.